Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
cancer
7
×
clinical trials
7
×
life sciences
national blog main
new york blog main
san francisco blog main
biotech
national top stories
new york top stories
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
fda
merck
nivolumab
blueprint medicines
cancer immunotherapy
cell therapy
cvs health
diagnostics
dna sequencing
eli lilly
What
new
7
×
drug
cancer
companies
ipo
medicines
bio
brings
million
roundup
targets
therapeutics
advantages
aim
approval
approved
bar
based
begin
biogen’s
biopharmaceutical
biosciences
biotech
biotechs
bio’s
black
boost
bubbles
cells
change
class
clinic
clinical
club
codiak
community
continued
convo
crop
deeper
Language
unset
Current search:
new
×
cancer
×
" clinical trials "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M